Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Vroegtijdig kanker ontdekken in druppel bloed
nov 2020 | Borstkanker, Longoncologie, Neuro-oncologie